As PTPN2 and PTPN6 have been shown to negatively regulate insulin action, the identification of inhibitors of these proteins is considered an effective strategy for the treatment or prevention of type 2 diabetes. This evidence concerns the gene PTPN2 and type 2 diabetes mellitus.